Immediate Impact
53 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
2024 Standout
Works of Naoki Morimoto being referenced
Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice
2022
Transcatheter arterial chemoembolization therapy in combination strategy with lenvatinib in patients with unresectable hepatocellular carcinoma (TACTICS-L) in Japan: Final analysis.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Naoki Morimoto | 210 | 139 | 108 | 193 | 59 | 681 | |
| Yixing Chen | 90 | 78 | 229 | 210 | 49 | 735 | |
| Hisanori Shiomi | 92 | 54 | 229 | 170 | 53 | 657 | |
| Yoshikane Yamauchi | 133 | 39 | 230 | 448 | 63 | 807 | |
| Krishna Pillai | 86 | 73 | 141 | 164 | 37 | 736 | |
| Vittorio Albino | 210 | 99 | 196 | 114 | 43 | 745 | |
| Xu-Dong Qu | 486 | 150 | 196 | 144 | 40 | 810 | |
| Yasuto Takeuchi | 311 | 223 | 132 | 68 | 64 | 699 | |
| Wenqing Wang | 56 | 53 | 199 | 231 | 70 | 580 | |
| Yoji Iwasaki | 211 | 130 | 208 | 266 | 63 | 763 | |
| Daniela Brambilla | 50 | 46 | 142 | 417 | 40 | 847 |
All Works
Login with ORCID to disown or claim papers
Loading papers...